US2005020529A1PendingUtilityA1
Delivery construct for antisense nucleic acids and methods of use
Est. expiryOct 31, 2016(expired)· nominal 20-yr term from priority
Inventors:Harry C. Dietz
A61K 38/00C12N 2310/53C12N 2310/111A01K 2217/05C12N 2310/121C12N 15/113A61K 48/00
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A novel nucleic acid construct for delivery of antisense targeting sequences is provided. The construct includes intact stem loop structures and an antisense nucleic acid. Optionally, a ribozyme nucleic acid is included in the construct. The construct is useful for inhibition of selected genes in a cell. This allele-specific targeting is also useful in combination with replacement gene therapy.
Claims
exact text as granted — not AI-modified1 . A nucleic acid construct for suppressing gene expression comprising in 5′ to 3′ operable orientation:
a 5′ stem loop structure; an antisense nucleic acid; and a 3′ stem loop structure wherein the antisense nucleic acid suppresses gene expression and is flanked by the stem loop structures and with the proviso that the antisense nucleic acid is not within a stem loop structure of the construct.
2 . The nucleic acid construct of claim 1 , wherein the stem loop structures are unmodified U snRNA structures.
3 . The nucleic acid construct of claim 2 , wherein the U snRNA is U1.
4 . The nucleic acid construct of claim 1 , further comprising a promoter.
5 . The nucleic acid construct of claim 4 , wherein the promoter is a U1 snRNA promoter.
6 . The nucleic acid construct of claim 4 , wherein the promoter is a constitutive promoter.
7 . The nucleic acid construct of claim 4 , wherein the promoter is an inducible promoter.
8 . The nucleic acid construct of claim 1 , further comprising a ribozyme nucleic acid.
9 . The nucleic acid construct of claim 8 , wherein the ribozyme nucleic acid is located between the 5′ and 3′ stem loop structures.
10 . The nucleic acid construct of claim 8 , wherein the ribozyme nucleic acid is a hammerhead-type ribozyme.
11 . The nucleic acid construct of claim 8 , wherein a consensus sequence for ribozyme cleavage in a target nucleic acid is 5′-GUC-3′ or 5′-GUA-3′.
12 . The nucleic acid construct of claim 1 , wherein the antisense nucleic acid is selected from the group consisting of rent-1, HPV E6, HIV, hyaluronic acid synthase, and fibrillin.
13 . A method for suppression of gene expression comprising administering to a cell in vitro a suppressive-effective amount of the nucleic acid construct of claim 1 , whereby expression of the gene is suppressed in the cell.
14 - 19 (Canceled)Join the waitlist — get patent alerts
Track US2005020529A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.